Disc: Hold!
Printable View
Depending on how the squiggly line is going I've been small, medium, large and XL
And the company did get 15 grand of my cash a while ago
Patience, patience and more patience.
That is kind of what PEB is about now - according to the directors and management of PEB.
Meanwhile, they are not prepared to be forthcoming with regular updates (like DIL in its earlier years) to provide shareholders and investors a feel of how they are going and track their performance. Just be patient and trust them.
Not for me, I have seen and experienced too many of the 'trust us, we know what we are doing' directors and management over the decades - all care and no transparency/accountability.
I have reduced my stake hugely and I believe there will be plenty of opportunities in the years ahead to get reset in PEB if they do deliver.
Judging by the comments from the AGM, I would say they would not be shy to raise more capital to 'leverage' off their sales 'success'.
Good luck to all the XL shareholders and for my 'Large' shareholding , here's hoping they deliver and I look forward to investing more when they deliver.
Capital costs as above, COGS as estimated by Pacific Edge, royalties to Cellmid outside of COGS, corporate governance, and all the usual accountable items. As far as modelling goes it’s really not a particularly complex exercise to replicate if one references and applies company provided targets.
The Edison effort though may be a little more complex and interesting, as unlike the local brokers and investors, they have their own specialist within sector analysts basedin the UK and US. They may very well build a model based on independent market research and an estimate of the efficacy of Cxbladder within that market, rather than building a model based on company estimated targets.
Meanwhile, every offer that gets placed at 72c is soon after matched by a buyer placing at the same price a larger bid. Fight it out boys.
I agree with Hoop that technically PEB is now looking like the bulls are more in control (for the first time this year!) with an upward trendline in the making. This month's foot and knee pattern has held firm (at 62c and 64c) and the sharp lift through 70c yesterday has not been reversed by any negative sentiment or cynicism arising from investor reaction to the AGM.
Like other posters, I too am not impressed by Management reluctance to be transparent regarding Sales figures for the past three months (which would not be hard to dig out) and their either arrogant or (more kindly) naive attitude towards disgruntled investors, expecting us to effectively suck it up and simply trust them...but this pup may now have some legs to get up a lot closer to $1...in spite of its already inflated Market Cap.
Discl: holding, but ready to sell on any indicated weakness.
Well said.
When I see them hit one over the boundary fence and score a six I'll get interested again and not before.
With some previously alleged controversial director behaviour ("pump and dump") I'd be very cautious giving these guys too much trust.Trust is earned, not given.
Well I jumped in, (65) purely from the FA prospective that,before all the hype,I reckon this is about where it should have been (70s)--but it is good to hear your TA opinion as well Hoop and BC.
I think its time to start thinking of this co as hopefully a solid slow growth co with potential and not some get rich quick scheme.
This is not a product that Americans are going to hear about and rush out and buy(like the latest tech toy)
Its a medical test that will need time to hopefully be successful and save some lives at the same time if the management are up to scratch--Thats where Ive given them the benefit of the doubt at this price ,at this point in time.
Up to the next sales figures ,it will most likely depend on whether SH and institutions agree or if they get someone on board like a US co or insurance outfit who would spike sales along